USD
+$0.00
(+0.00%
)At Close (As of Sep 15, 2025)
$75.61M
Market Cap
-
P/E Ratio
-2.58
EPS
$4.06
52 Week High
$0.89
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $40M |
Total Revenue | $53M |
Cost Of Revenue | $1.9M |
Costof Goods And Services Sold | $1.9M |
Operating Income | -$94M |
Selling General And Administrative | $30M |
Research And Development | $116M |
Operating Expenses | $134M |
Investment Income Net | - |
Net Interest Income | $10M |
Interest Income | $10M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.9M |
Income Before Tax | -$83M |
Income Tax Expense | $1.4M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$85M |
Comprehensive Income Net Of Tax | - |
Ebit | -$92M |
Ebitda | -$90M |
Net Income | -$85M |
Field | Value (USD) |
---|---|
Total Assets | $177M |
Total Current Assets | $171M |
Cash And Cash Equivalents At Carrying Value | $85M |
Cash And Short Term Investments | $85M |
Inventory | - |
Current Net Receivables | $12M |
Total Non Current Assets | $5.4M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $68M |
Other Current Assets | $6M |
Other Non Current Assets | - |
Total Liabilities | $25M |
Total Current Liabilities | $25M |
Current Accounts Payable | $3.6M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.8M |
Total Non Current Liabilities | $88K |
Capital Lease Obligations | $1.9M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.9M |
Other Current Liabilities | $20M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $151M |
Treasury Stock | - |
Retained Earnings | -$418M |
Common Stock | $487M |
Common Stock Shares Outstanding | $42M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$76M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.9M |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $49M |
Cashflow From Financing | $542K |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $525K |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$85M |
Field | Value (USD) |
---|---|
Gross Profit | $40M |
Total Revenue | $53M |
Cost Of Revenue | $1.9M |
Costof Goods And Services Sold | $1.9M |
Operating Income | -$94M |
Selling General And Administrative | $30M |
Research And Development | $116M |
Operating Expenses | $134M |
Investment Income Net | - |
Net Interest Income | $10M |
Interest Income | $10M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.9M |
Income Before Tax | -$83M |
Income Tax Expense | $1.4M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$85M |
Comprehensive Income Net Of Tax | - |
Ebit | -$92M |
Ebitda | -$90M |
Net Income | -$85M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Repair Therapeutics Inc., a precision oncology company, discovers and develops novel therapies using its synthetic lethality approach in Canada and the United States. The company is headquartered in Montral, Canada.